Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-5204
Fax+1 617-632-3408
Dr. Merriam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Hematology and Medical Oncology, 2013
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2006
Certifications & Licensure
NH State Medical License 2023 - 2027
CT State Medical License 2022 - 2025
MA State Medical License 2013 - 2025
ME State Medical License 2022 - 2025
RI State Medical License 2006 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
Publications & Presentations
PubMed
- Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.Erica M Pimenta, Amanda E Garza, Sabrina Y Camp, Jihye Park, Samantha E Hoffman
Biorxiv. 2025-01-24 - 3 citationsSafety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.Gregory M Cote, Candace L Haddox, Edwin Choy, Priscilla A Merriam, Emanuele Mazzola
Clinical Cancer Research. 2024-07-01 - 17 citationsPhase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska
Clinical Cancer Research. 2024-04-01
Press Mentions
Dana-Farber Experts Present Innovative Cancer Studies at the 2025 AACR Annual MeetingApril 26th, 2025- Dana-Farber Research Highlights Head and Neck, Breast, Lung, and Survivorship Studies at AACR Annual Meeting 2025April 25th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
